C. Favaron

Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib

M. Cazzola, F. Baldanti, M. Furione, 2020, Hematological oncology.

The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme.

M. Bottone, P. Rossi, E. Roda, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms

M. Cazzola, L. Arcaini, V. Ferretti, 2019, American journal of hematology.

Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme

M. Bottone, P. Rossi, E. Roda, 2023, Apoptosis.